Page 6 - Pharma Stocks

Breakout stocks: Nifty Pharma, Biocon, Cipla break over 200-DMA; what next?

The Nifty Pharma index and select shares such as Biocon, Cipla, Zydus Life and Gland Pharma were trading above the respective 200-DMAs after more than 2 months; show technical charts.

Rekha Jhunjhunwala portfolio stock soars 17%; zooms over 950% in 2 years

Shares of Wockhardt hit an all-time high of ₹1,809.95, as they rallied 17% on the BSE in Wednesday's intra-day trade surpassed its previous high of ₹1,678.60 touched on February 6, 2025.

Marksans Pharma shares surge 5% after block trades; details here

Marksans Pharma shares rose 5 per cent after 10.27 million shares changed hands via multiple pre-market block trades

Mukul Agrawal portfolio stock hits record high; zooms 75% from March low

Shares of OneSource Specialty Pharma hit a new high of ₹2,031.45 in Tuesday's intra-day trade in otherwise a subdued market and rallied 28% in the past month

Lower US growth trajectory, margin pressures ahead for Zydus Lifesciences

In the US market, robust growth in the base portfolio, new launches and generic version of Myrbetriq (for overactive bladder) aided its revenue effort in that market

Gland Pharma share rises 2% in trade on Wednesday, June 4; here's why

Gland Pharma shares rose after it secured United States Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA) for Angiotensin II Acetate Injection 2.5 mg/mL.

Biocon share price pops 2% on CDSCO nod for diabetes drug; key details here

Biocon's share price saw an uptick following key regulatory approvals in India for its Liraglutide drug, which is used in the treatment of type 2 diabetes.

AstraZeneca Pharma rises 2% on securing CDSCO nod for Benralizumab solution

AstraZeneca Pharma shares rose on receiving nod from the CDSCO, to import for sale and distribution of Benralizumab 30 mg/ml solution for injection (brand name: Fasenra) for an additional indication.

Concord Biotech share price pops 6% on healthy Q4 nos; profit zooms 48% YoY

Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

Here's why Natco Pharma share price is buzzing in trade on Thursday, May 29

Natco Pharma share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

These 5 pharma stocks can fall up to 12% as technical charts flag caution

Abbott India, Aurobindo Pharma, Cipla, Dr Lal PathLabs and Torrent Pharma flag caution signals on technical charts; here are the key levels to watch out for.

Bajaj Healthcare slips 9% on weak Q4 operational performance; details here

Bajaj Healthcare share price dropped today on the back of weak operational performance in the March quarter of FY25 (Q4FY25).

Divi's Labs share up 4%, hits record high on inking supply deal; details

Divi's Laboratories share price rose after the company announced that it has inked a long-term manufacturing and supply agreement with a global pharmaceutical company.

What drove Indoco Remedies share price 6% higher today? Top details inside

Indoco Remedies' share price rose after the company received final USFDA approval for its ANDA to market Allopurinol tablets USP, 200 mg - a generic version of Zyloprim 200 mg by Casper Pharma LLC.

Sensex rises 410 pts, Nifty tops 24,800; analysts foresee 'sell on rallies'

The Sensex settled at 81,596.63, up 410.19 points or 0.51 per cent, while the Nifty50 closed at 24,813.45, gaining 129.55 points or 0.52 per cent

Zydus Life Q4 profit falls 1% YoY; ₹11 dividend declared; stock down 2%

Zydus Lifesciences consolidated net profit slipped about 1 per cent year-on-year (Y-o-Y) to ₹1,171 crore in the March quarter of financial year 2025 (Q4FY25), from ₹1,182 crore in Q4FY24.

Sun Pharma Q4 preview: Analysts expect 18% jump in profit; check details

Sun Pharma Q4 results date: Sun Pharma is scheduled to announce its fourth quarter results on Thursday, May 22, 2025

Pfizer share climbs 11% post healthy Q4; announces Rs 165 dividend for FY25

Pfizer shares climbed after the company reported a strong set of March quarter results on May 19, 2025.

Piramal Pharma stock falls 5% after Q4 results; check key numbers here

Piramal Pharma stock was down 4.5 per cent at ₹209 compared to the previous day's close of ₹219.04 on the NSE

Here's why Marksans Pharma share price increased over 2% in trade on May 15

At 11:20 PM, Marksans Pharma shares pared gains and were trading merely 0.08 per cent higher at Rs 238 per share. In comparison, BSE Sensex was trading 0.10 per cent lower at 81,247.08 level.